These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 667853)

  • 1. Isolation and identification of a metabolic intermediate in the selective dechloroethylation of one of the four stereoisomers of 4-methylcyclophosphamide.
    Abel G; Cox PJ; Farmer PB; Haskins NJ; Jarman M; Meral K; Stec WJ
    Cancer Res; 1978 Aug; 38(8):2592-9. PubMed ID: 667853
    [No Abstract]   [Full Text] [Related]  

  • 2. Stereoselectivity in the metabolism of the enantiomers of cyclophosphamide in mice, rats, and rabbits.
    Cox PJ; Farmer PB; Jarman M; Kinas RW; Stec WJ
    Drug Metab Dispos; 1978; 6(6):617-22. PubMed ID: 33022
    [No Abstract]   [Full Text] [Related]  

  • 3. The microsomal metabolism of some analogues of cyclophosphamide: 4-methylcyclophosphamide and 6-methylcyclophosphamide.
    Cox PJ; Farmer PB; Jarman M
    Biochem Pharmacol; 1975 Mar; 24(5):599-606. PubMed ID: 1125063
    [No Abstract]   [Full Text] [Related]  

  • 4. The metabolism and antitumour activity of the enantiomers of cis- and trans-4-methylcyclophosphamide.
    Farmer PB; Jarman M; Facchinetti T; Pankiewicz K; Stec WJ
    Chem Biol Interact; 1977 Jul; 18(1):47-57. PubMed ID: 890840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunosuppressant effect of cyclophosphamide activated in vitro by liver microsomes from different strains of mice].
    Telegin LIu; Zhirnov GF; Mazurov AV; Pevnitskiĭ LA
    Biull Eksp Biol Med; 1981 Jul; 92(7):57-60. PubMed ID: 7295946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of cis- and trans-4-methylcyclophosphamide and antitumor evaluation in vivo.
    Struck RF; Thorpe MC; Coburn WC; Kirk MC
    Cancer Res; 1975 Nov; 35(11 Pt 1):3160-3. PubMed ID: 1182706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioassay and relative cytotoxic potency of cyclophosphamide metabolites generated in vitro and in vivo.
    Sladek NE
    Cancer Res; 1973 Jun; 33(6):1150-8. PubMed ID: 4718666
    [No Abstract]   [Full Text] [Related]  

  • 8. Permeation of cyclophosphamide (NSC-26271) metabolites into tumor cells.
    Draeger U; Hohorst HJ
    Cancer Treat Rep; 1976 Apr; 60(4):423-7. PubMed ID: 1277217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of deuterated analogs in qualitative and quantitative investigations of the metabolism of cyclophosphamide (NSC-26271).
    Cox PJ; Farmer PB; Foster AB; Gilby ED; Jarman M
    Cancer Treat Rep; 1976 Apr; 60(4):483-91. PubMed ID: 1277225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue and species specificity of the microsomal metabolism of N-nitrosomethylbenzylamine.
    Mehta R; Labuc GE; Archer MC
    IARC Sci Publ; 1984; (57):473-8. PubMed ID: 6533039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in benzo(a)pyrene metabolism between rodent liver microsomes and embryonic cells.
    Selkirk JK; Croy RG; Wiebel FJ; Gelboin HV
    Cancer Res; 1976 Dec; 36(12):4476-9. PubMed ID: 1000495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsomal activation of cyclophosphamide in vivo.
    Connors TA; Grover PL; McLoughlin AM
    Biochem Pharmacol; 1970 Apr; 19(4):1533-5. PubMed ID: 4398015
    [No Abstract]   [Full Text] [Related]  

  • 13. Role of cytochrome P450 in oxazaphosphorine metabolism. Deactivation via N-dechloroethylation and activation via 4-hydroxylation catalyzed by distinct subsets of rat liver cytochromes P450.
    Yu L; Waxman DJ
    Drug Metab Dispos; 1996 Nov; 24(11):1254-62. PubMed ID: 8937861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemia.
    Hilton J
    Cancer Res; 1984 Nov; 44(11):5156-60. PubMed ID: 6488175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of substrate configuration on chlorpheniramine N-demethylation by hepatic microsomes from rats, rabbits, and mice.
    Thompson JA; Shioshita GW
    Drug Metab Dispos; 1981; 9(1):5-9. PubMed ID: 6111432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic efficacy of cyclophosphamide as a function of its metabolism.
    Sladek NE
    Cancer Res; 1972 Mar; 32(3):535-42. PubMed ID: 5061308
    [No Abstract]   [Full Text] [Related]  

  • 17. Stereochemistry, metabolism, and antitumor activity of 4-hydroperoxyisophosphamide (NSC-227114) and its stereoisomer.
    Takamizawa A; Iwata T; Yamaguchi K; Shiratori O; Harada M
    Cancer Treat Rep; 1976 Apr; 60(4):361-8. PubMed ID: 1277212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of cyclophosphamide as a function of inhibition of its metabolism.
    Sladek NE
    Cancer Res; 1972 Sep; 32(9):1848-54. PubMed ID: 4641276
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of induced tumour-resistance to cyclophosphamide by the in vitro short term test.
    Volm M; Mattern J; Wayss K
    Arch Gynakol; 1977 Nov; 223(4):249-57. PubMed ID: 579579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of cytotoxic action of iphosphamide and cyclophosphamide.
    Phelan ET; Vietti TJ; Valeriote FA; Coulter D
    Anticancer Res; 1981; 1(3):149-54. PubMed ID: 7342853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.